1. REVIEW OF COMPLEMENT SYSTEMKHADIZHA EMIROVA (Russia) Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov 2. Complement system  system of blood…

Understanding Optimal Use and Interpretation of Assays in HCV This program is supported by educational grants from Understanding the Optimal Use and Interpretation of Assays…

1. Cholesterol LoweringA Failed Strategy 2. Animal studies show significant reductions in atherosclerosis unrelated tocholesterol levels. Few examples: 3. Therefore, animal…

1. Section of Critical Care Medicine Section of Infectious Diseases University of Manitoba, Winnipeg, Canada UMDNJ-Robert Wood Johnson Medical School Cooper Hospital, NJ…

This program is supported by an educational grant from Managing the Difficult-to-Treat HCV Patient clinicaloptions.com/hep Managing the Difficult-to-Treat HCV Patient About…

1. Health Literacy views: The clinician viewpointBarcelona.January 14 th , 2008 Joan Escarrabill MD Hospital Universitari de Bellvitge L’Hospitalet (Barcelona) [email_address]…

1. CVD Critical Pathways Group2006 Teleconferences March 22, 2006 This activity is supported by an educational grant from theBristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.…

1. Endovascular Neurosurgery Dr Mukhtar Neurosurgery HMC 2. Aims • Introduction to endovascular neurosurgery • Importance of endovascular neurosurgery • Basic know…

1. Erwin B. Montgomery Jr. MDMedical Director, Greenville Neuromodulation CenterThe Greenville Neuromodulation Scholar in Neuroscience and Philosophy,Thiel College, Greenville…

1. E.B.M. FOR MYTHICAL BEASTS NATHAN CLEVELAND, MD, MS UNIVERSITY MEDICAL CENTER LAS VEGAS, NV 2. E.B.M. FOR MYTHICAL BEASTS TITLE DOGMA INTRO CLASSIFICATION GOALS E.B.M.…